Augmedix Announces Expanding Coverage in Behavioral Health Field for Acute and Ambulatory Care Settings
06 September 2023 - 9:00PM
Augmedix (Nasdaq: AUGX), a healthcare technology company that
delivers industry-leading, ambient medical documentation and data
solutions, announced today the expansion of the company’s medical
documentation products to the behavioral healthcare field.
As the need for behavioral healthcare continues
to grow, Augmedix is proud to successfully serve the behavioral
health field by offering ambient medical documentation and data
solutions that are accurate and transparent, and which help
streamline workflows for clinicians. Augmedix currently supports
behavioral healthcare entities with its Augmedix Live and Augmedix
Notes products, and will supplement those with its newest product,
Augmedix Go, later this year.
“To address the increasing need for behavioral
healthcare services, which has been exacerbated by the mental
healthcare workforce shortage, Augmedix is expanding its service
offerings to cover this pressing issue in our society today,” said
Manny Krakaris, Chief Executive Officer of Augmedix. “Augmedix
enables health systems partners like Northern Light Health to put
the clinician-patient relationship front and center in behavioral
health settings as well as other specialty settings. We facilitate
a more natural interaction and document patient visits with
comprehensive and accurate medical notes.”
By digitizing the patient encounter, Augmedix
streamlines medical documentation and access to data and frees
clinicians to fully engage with their patients. The company’s
offerings can be utilized in ambulatory and acute behavioral
healthcare settings such as counseling, psychiatric services,
clinics, telehealth, inpatient, and more. Augmedix products are
utilized by a wide spectrum of behavioral health professionals,
including nurse practitioners and psychiatrists. Across the more
than 35 specialties that Augmedix serves, patients consent to the
use of Augmedix at a 99% acceptance rate.
Nearly half of psychologists report burnout or
the inability to meet patient demand. Augmedix can help alleviate
the increased workload, and clinicians using Augmedix products can
save up to three hours per day.
“As a psychiatrist, Augmedix helps me document
quickly and efficiently, leaving more time and energy for patient
care,” said Amelia Villagomez, MD, Integrative Psychiatrist at
Mindful. “Through the medical documentation and data provided, I am
able to streamline workflows and have an extra hour every day.”
About Augmedix
Augmedix (Nasdaq: AUGX) delivers
industry-leading, ambient medical documentation and data solutions
to healthcare systems, physician practices, hospitals, and
telemedicine practitioners.
Augmedix is on a mission to help clinicians and
patients form a human connection at the point of care, through
technology that works in the background and does not interfere with
the clinician-patient encounter. Augmedix’s proprietary Notebuilder
Platform extracts relevant data from natural clinician-patient
conversations and converts that data into medical notes in real
time, which are seamlessly transferred to the EHR. The company’s
platform uses automatic speech recognition, natural language
processing, including large language models, and medical
documentation specialists to generate accurate and timely medical
notes.
Leveraging this platform, Augmedix’s products
relieve clinicians of administrative burden, in turn, reducing
burnout and increasing both clinician and patient satisfaction.
Augmedix is also leading the revolution in transforming
point-of-care information into valuable structured data that can
drive lower revenue cycle management costs, higher reimbursement
levels and deliver important clinical feedback to the point of
care.
Augmedix is headquartered in San Francisco, CA,
with offices around the world. To learn more, visit
www.augmedix.com.
Contact Information
Investors:Matt Chesler, CFAFNK
IR646-809-2183augx@fnkir.cominvestors@augmedix.com
Media: Kaila GrafemanAugmedixpr@augmedix.com
Forward-Looking Statements
This press release contains “forward-looking
statements” that involve a number of risks and uncertainties. Such
forward-looking statements include, without limitation, statements
regarding the intended and expected benefits of Augmedix’s medical
documentation services, the increasing need for behavioral health
services and the timing of the release of Augmedix Go for
behavioral health. Actual results could differ materially from
those stated or implied in forward-looking statements due to a
number of factors, including but not limited to, risks detailed in
our most recent Form 10-K filed with the U.S. Securities and
Exchange Commission on April 17, 2023, as well as other documents
that may be filed by us from time to time with the U.S. Securities
and Exchange Commission. The forward-looking statements included in
this press release represent our views as of the date of this press
release. We undertake no intention or obligation to update or
revise any forward-looking statements, whether as a result of new
information, future events or otherwise. These forward-looking
statements should not be relied upon as representing our views as
of any date subsequent to the date of this press release.
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Apr 2024 to May 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From May 2023 to May 2024